Streetbeat News

Analyst Ratings

DAY

Dayforce (NYSE:DAY) has received mixed analyst ratings over the past three months, with a majority being bullish or somewhat bullish. The average 12-month price target has slightly increased to $69.0. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments. Dayforce has shown strong revenue growth but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 1:00 pm

COMP

Compass (NYSE:COMP) has received varied analyst ratings over the past quarter, with a mix of bullish and somewhat bullish sentiments. Analysts have raised their price targets, indicating a positive outlook. The company's financial performance shows strong revenue growth and efficient cost management, but it faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 1:00 pm

FBLG

Maxim Group has initiated coverage on FibroBiologics with a Buy rating and set a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:59 pm

AIR

RBC Capital analyst Ken Herbert has reiterated an Outperform rating for AAR Corp (NYSE:AIR) and maintained a price target of $85.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:58 pm

BRZE

Loop Capital has reiterated its Buy rating on Braze (NASDAQ:BRZE) and maintained a price target of $75.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:54 pm

CTAS

Cintas Corporation (NASDAQ:CTAS) is set to release its Q1 earnings on Sept. 25, with expectations of increased earnings per share and revenue. Analysts have recently adjusted their ratings and price targets for Cintas, reflecting varied outlooks on the stock.

Portfolio Pulse from Avi Kapoor

September 24, 2024 | 12:52 pm

PINS

Oppenheimer has initiated coverage on Pinterest with an Outperform rating and set a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:51 pm

LUMO

EF Hutton has initiated coverage on Lumos Pharma with a Buy rating and set a price target of $16, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:51 pm

ALTM

RBC Capital has reiterated its Outperform rating on Arcadium Lithium (NYSE:ALTM) and maintained a price target of $3.1.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:51 pm

BANC

BNTX

BRZE

CART

CELH

CMA

HUT

LNW

MCK

XOM

Top Wall Street analysts have updated their price targets and ratings for several companies, including Exxon Mobil, Hut 8, McKesson, BioNTech, Banc of California, Maplebear, Comerica, Celsius Holdings, Braze, and Light & Wonder. These changes reflect varying outlooks on the stocks, with some being upgraded and others downgraded.

Portfolio Pulse from Avi Kapoor

September 24, 2024 | 12:50 pm